CC BY-NC-ND 4.0 · South Asian J Cancer 2016; 05(03): 122-124
DOI: 10.4103/2278-330X.187577
Review Article

Genitourinary cancers: Summary of Indian data

T. B. Yuvaraja
Department of Uro-oncology and Robotic Surgery, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra
,
Santosh Waigankar
Department of Uro-oncology and Robotic Surgery, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra
,
Ganesh Bakshi
Department of Uro-oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Gagan Prakash
Department of Uro-oncology, Tata Memorial Hospital, Mumbai, Maharashtra
› Author Affiliations
Financial support and sponsorship: Nil.

Abstract

Tumors of the genitourinary system are one of the most common tumors encountered in clinical practice. The associated morbidity and mortality and the significant proportion of affected middle-age individuals have a major bearing on the death-adjusted life years compared to other malignancies. Genitourinary system tumors encompass a very broad spectrum with regard to age, location, histology, and clinical outcomes. Advances in diagnostic imaging, surgical techniques, radiotherapy equipment, and generation of newer chemotherapeutic and targeted agents over the past few years have helped improving treatment outcome. Several focused groups within India have been working on a range of topics related to genitourinary system tumors, and a significant body of work from India in the recent years is being increasingly recognized throughout the world. The present article summarizes the key published work related to the epidemiology of genitourinary system tumors in the Indian setting. A PubMed search was made for locating and selecting articles relevant to the topic.



Publication History

Article published online:
28 December 2020

© 2016. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sharma RG, Kumar R, Jain S, Jhajhria S, Gupta N, Gupta SK, et al. Distribution of malignant neoplasms reported at different pathology centers and hospitals in Jaipur, Rajasthan. Indian J Cancer 2009;46:323-30.
  • 2 Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer Incidence in Five Continents. Vol. VIII. Lyon, France: IARC Publications No. 155; 2002.
  • 3 Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology 2005;66 6 Suppl 1:4-34.
  • 4 Gupta P, Jain M, Kapoor R, Muruganandham K, Srivastava A, Mandhani A. Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol 2009;25:207-10.
  • 5 Biswas RR, Mangal S, Guha D, Basu K, Karmakar D. An Epidemiological Study of Cases of Urothelial Carcinoma of Urinary Bladder in a Tertiary Care Centre. JKIMSU 2013;2.
  • 6 Yeole BB, Jussawalla DJ. Descriptive epidemiological assessment of urinary bladder and kidney cancers in Greater Bombay. Indian J Med Res 1997;106:517-23.
  • 7 Pahwa M, Girotra M, Rautela A, Abrahim R. Penile cancer in India: A clinicoepidemiological study. Gulf J Oncolog 2012;(12):7-10.
  • 8 Agnihotri S, Kumar J, Jain M, Kapoor R, Mandhani A. Renal cell carcinoma in India demonstrates early age of onset and a late stage of presentation. Indian J Med Res 2014;140:624-9.
  • 9 Sivaramakrishna B, Gupta NP, Wadhwa P, Hemal AK, Dogra PN, Seth A, et al. Pattern of metastases in renal cell carcinoma: A single institution study. Indian J Cancer 2005;42:173-7.
  • 10 Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
  • 11 Yeole BB. Trends in the prostate cancer incidence in India. Asian Pac J Cancer Prev 2008;9:141-4.
  • 12 Jain S, Saxena S, Kumar A. Epidemiology of prostate cancer in India. Meta Gene 2014;2:596-605.
  • 13 Tyagi B, Manoharan N, Raina V. A case control study on prostate cancer in Delhi. Asian Pac J Cancer Prev 2010;11:397-401.
  • 14 Ganesh B, Saoba SL, Sarade MN, Pinjari SV. Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India. Indian J Urol 2011;27:345-50.